Another Flurry of Deals—BG Medicine’s IPO, EnerNOC Trims Offering, Venture Rounds, and More

Looks like maybe we should have waited a day to post yesterday morning’s roundup of recent deals, because the rest of the day brought a flurry of new deals news.

—Molecular diagnostics firm BG Medicine of Waltham, MA, set the terms for its IPO at 4.5 million shares priced between $14 and $16. Bob had some nice background on the deal (including why the company plans to trade on an Amsterdam exchange) back in August when it was first filed.

—Boston’s EnerNOC, an energy demand aggregator, priced its secondary public offering at $43 per share. The firm also downsized the deal from the originally specified 4 million shares to 2.5 million shares, according to the research firm Morningnotes.

—CaseNET, a Boston-based healthcare software firm, raised $7.5 million in a Series B financing. The deal was led by HLM Venture Partners.

—Lexington, MA-based FirstBest Systems announced it had closed a $7 million Series A round led by IDG Ventures Boston. FirstBest offers automated web-based systems for insurance underwriting.

—KoolConnect Technologies, a Needham, MA-based provider of digital on-demand media services for hotels, raised $6.5 million of a $10.5 million round of financing led by the U.K.’s Lewis Trust Group.

—Framingham, MA’s Vivox, which offers voice services for online gaming and virtual-reality applications, raised $7.8 million in a second round led by Benchmark Capital.

Author: Rebecca Zacks

Rebecca is Xconomy's co-founder. She was previously the managing editor of Physician's First Watch, a daily e-newsletter from the publishers of New England Journal of Medicine. Before helping launch First Watch, she spent a decade covering innovation for Technology Review, Scientific American, and Discover Magazine's TV show. In 2005-2006 she was a Knight Science Journalism Fellow at MIT. Rebecca holds a bachelor's degree in biology from Brown University and a master's in science journalism from Boston University.